Literature DB >> 27339256

Long-Term Selenium-Deficient Diet Induces Liver Damage by Altering Hepatocyte Ultrastructure and MMP1/3 and TIMP1/3 Expression in Growing Rats.

Jing Han1, Hua Liang2, Jianhua Yi1, Wuhong Tan1, Shulan He3, Sen Wang1, Feng Li4, Xiaofang Wu1, Jing Ma5, Xiaowei Shi6, Xiong Guo7, Chuanyi Bai8.   

Abstract

The effects of selenium (Se)-deficient diet on the liver were evaluated by using growing rats which were fed with normal and Se-deficient diets, respectively, for 109 days. The results showed that rats fed with Se-deficient diet led to a decrease in Se concentration in the liver, particularly among male rats from the low-Se group. This causes alterations to the ultrastructure of hepatocytes with condensed chromatin and swelling mitochondria observed after low Se intake. Meanwhile, pathological changes and increased fibrosis in hepatic periportal were detected by hematoxylin and eosin and Masson's trichrome staining in low-Se group. Furthermore, through immunohistochemistry (IHC) staining, higher expressions of metalloproteinases (MMP1/3) and their tissue inhibitors of metalloproteinases (TIMP1/3) were observed in the hepatic periportal of rats from the low-Se group. However, higher expressions of MMP1/3 and lower expressions of TIMP1/3 were detected in hepatic central vein and hepatic sinusoid. In addition, upregulated expressions of MMP1/3 and downregulated expressions of TIMP1/3 at the messenger RNA (mRNA) and protein levels also appeared to be relevant to low Se intake. In conclusion, Se-deficient diet could cause low Se concentration in the liver, alterations of hepatocyte ultrastructure, differential expressions of MMP1/3 and TIMP1/3 as well as fibrosis in the liver hepatic periportal.

Entities:  

Keywords:  Liver; Low selenium; MMP; Pathological changes; TIMP

Mesh:

Substances:

Year:  2016        PMID: 27339256     DOI: 10.1007/s12011-016-0781-5

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  5 in total

1.  Protective Effect of Mitophagy Regulated by mTOR Signaling Pathway in Liver Fibrosis Associated with Selenium.

Authors:  Lichun Qiao; Ziwei Guo; Haobiao Liu; Jiaxin Liu; Xue Lin; Huan Deng; Xuan Liu; Yan Zhao; Xiang Xiao; Jian Lei; Jing Han
Journal:  Nutrients       Date:  2022-06-10       Impact factor: 6.706

2.  Selenium Nanoparticles (SeNPs) Immunomodulation Is More Than Redox Improvement: Serum Proteomics and Transcriptomic Analyses.

Authors:  Ivan Fan Xia; Hang-Kin Kong; Margaret M H Wu; Yishan Lu; Ka-Hing Wong; Kevin W H Kwok
Journal:  Antioxidants (Basel)       Date:  2022-05-13

Review 3.  The Role and Mechanisms of Selenium Supplementation on Fatty Liver-Associated Disorder.

Authors:  Lin Xu; Yuanjun Lu; Ning Wang; Yibin Feng
Journal:  Antioxidants (Basel)       Date:  2022-05-08

4.  A polyethylenimine-modified carboxyl-poly(styrene/acrylamide) copolymer nanosphere for co-delivering of CpG and TGF-β receptor I inhibitor with remarkable additive tumor regression effect against liver cancer in mice.

Authors:  Shuyan Liang; Jun Hu; Yuanyuan Xie; Qing Zhou; Yanhong Zhu; Xiangliang Yang
Journal:  Int J Nanomedicine       Date:  2016-12-13

5.  The association between non-alcoholic fatty liver disease (NAFLD) and advanced fibrosis with blood selenium level based on the NHANES 2017-2018.

Authors:  Jie Liu; Liao Tan; Zhaoya Liu; Ruizheng Shi
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.